[1]
|
Rebecca, L., Siegel, M., et al. (2018) Cancer Statistics, 2018. CA: A Cancer Journal for Clinicians, 68, 7-30. https://doi.org/10.3322/caac.21442
|
[2]
|
Ahmedin, J.D., Siegel, R., Ward, E., Hao, Y.P., Xu, J.Q., Murray, T. and Thun, M.J. (2008) Cancer Statistics. CA: A Cancer Journal for Clinicians, 58, 71-96.
https://doi.org/10.3322/CA.2007.0010
|
[3]
|
Bogani, G., Dowdy, S.C., Cliby, W.A., Ghezzi, F., Rossetti, D., Frigerio, L. and Mariani, A. (2016) Management of Endometrial Cancer: Issues and Controversies. European Journal of Gynaecological Oncology, 37, 6-12.
|
[4]
|
Bogani, G., Dowdy, S.C., Cliby, W.A., Ghezzi, F., Rossetti, D. and Mariani, A. (2014) Role of Pelvic and Para-Aortic Lymphadenectomy in Endometrial Cancer: Current Evidence. The Journal of Obstetrics and Gynaecology Research, 40, 301-311.
https://doi.org/10.1111/jog.12344
|
[5]
|
Bogani, G., Multinu, F., Dowdy, S.C., Cliby, W.A., Wilson, T.O., Gostout, B.S., Weaver, A.L., Borah, B.J., Killian, J.M., Bijlani, A., et al. (2016) Incorporating Robotic-Assisted Surgery for Endometrial Cancer Staging: Analysis of Morbidity and Costs. Gynecologic Oncology, 141, 218-224.
https://doi.org/10.1016/j.ygyno.2016.02.016
|
[6]
|
Colombo, N., Creutzberg, C., Amant, F., Bosse, T., Gonzalez-Martin, A., Ledermann, J., Marth, C., Nout, R., Querleu, D., Mirza, M.R., et al. (2016) ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-Up. International Journal of Gynecologic Cancer, 26, 2-30.
https://doi.org/10.1097/IGC.0000000000000609
|
[7]
|
Mariani, A., Dowdy, S.C., Cliby, W.A., Gostout, B.S., Jones, M.B., Wilson, T.O. and Podratz, K.C. (2008) Prospective Assessment of Lymphatic Dissemination in Endometrial Cancer: A Paradigm Shift in Surgical Staging. Gynecologic Oncology, 109, 11-18. https://doi.org/10.1016/j.ygyno.2008.01.023
|
[8]
|
Fotopoulou, C., Savvatis, K., Kraetschell, R., Schefold, J.C., Lichtenegger, W. and Sehouli, J. (2010) Systematic Pelvic and Aortic Lymphadenectomy in Intermediate and High-Risk Endometrial Cancer: Lymph-Node Mapping and Identification of Predictive Factors for Lymph-Node Status. The European Journal of Obstetrics & Gynecology and Reproductive Biology, 149, 199-203.
https://doi.org/10.1016/j.ejogrb.2009.12.021
|
[9]
|
Benedetti Panici, P., Basile, S., Maneschi, F., Alberto Lissoni, A., Signorelli, M., Scambia, G., Angioli, R., Tateo, S., Mangili, G., Katsaros, D., et al. (2008) Systematic Pelvic Lymphadenectomy vs. No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial. Journal of the National Cancer Institute, 100, 1707-1716. https://doi.org/10.1093/jnci/djn397
|
[10]
|
Group, A.S., Kitchener, H., Swart, A.M., Qian, Q., Amos, C. and Parmar, M.K. (2009) Efficacy of Systematic Pelvic Lymphadenectomy in Endometrial Cancer (MRC ASTEC Trial): A Randomised Study. The Lancet, 373, 125-136.
https://doi.org/10.1016/S0140-6736(08)61766-3
|
[11]
|
Frost, J.A., Webster, K.E., Bryant, A. and Morrison, J. (2017) Lymphadenectomy for the Management of Endometrial Cancer. Cochrane Database of Systematic Reviews, 10, CD007585. https://doi.org/10.1002/14651858.CD007585.pub4
|
[12]
|
Todo, Y., Kato, H., Kaneuchi, M., Watari, H., Takeda, M. and Sakuragi, N. (2010) Survival Effect of Para-Aortic Lymphadenectomy in Endometrial Cancer (SEPAL Study): A Retrospective Cohort Analysis. The Lancet, 375, 1165-1172.
https://doi.org/10.1016/S0140-6736(09)62002-X
|
[13]
|
Khoury-Collado, F., Murray, M.P., Hensley, M.L., Sonoda, Y., Alektiar, K.M., Levine, D.A., Leitao, M.M., Chi, D.S., Barakat, R.R. and Abu-Rustum, N.R. (2011) Sentinel Lymph Node Mapping for Endometrial Cancer Improves the Detection of Metastatic Disease to Regional Lymph Nodes. Gynecologic Oncology, 122, 251-254.
https://doi.org/10.1016/j.ygyno.2011.04.030
|
[14]
|
Gould, E.A., Winship, T., Philbin, P.H. and Kerr, H.H. (1960) Observations on a “Sentinel Node” in Cancer of the Parotid. Cancer, 13, 77-78.
https://doi.org/10.1002/1097-0142(196001/02)13:1<77::AID-CNCR2820130114>3.0.CO;2-D
|
[15]
|
Cabanas, R.M. (1977) An Approach for the Treatment of Penile Carcinoma. Cancer, 39, 456-466.
https://doi.org/10.1002/1097-0142(197702)39:2<456::AID-CNCR2820390214>3.0.CO;2-I
|
[16]
|
Burke, T.W., Levenback, C., Tornos, C., Morris, M., Wharton, J.T. and Gershenson, D.M. (1996) Intraabdominal Lymphatic Mapping to Direct Selective Pelvic and Paraaortic Lymphadenectomy in Women with High-Risk Endometrial Cancer: Results of a Pilot Study. Gynecologic Oncology, 62, 169-173.
https://doi.org/10.1006/gyno.1996.0211
|
[17]
|
Abu-Rustum, N.R. (2013) The Increasing Credibility of Sentinel Lymph Node Mapping in Endometrial Cancer. Annals of Surgical Oncology, 20, 353-354.
https://doi.org/10.1245/s10434-012-2685-8
|
[18]
|
Abu-Rustum, N.R. (2014) Sentinel Lymph Node Mapping for Endometrial Cancer: A Modern Approach to Surgical Staging. Journal of the National Comprehensive Cancer Network, 12, 288-297. https://doi.org/10.6004/jnccn.2014.0026
|
[19]
|
Koh, W.J., Abu-Rustum, N.R., Bean, S., Bradley, K., Campos, S.M., Cho, K.R., Chon, H.S., Chu, C., Cohn, D., Crispens, M.A., et al. (2018) Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 16, 170-199.
https://doi.org/10.6004/jnccn.2018.0006
|
[20]
|
Barlin, J.N., Khoury-Collado, F., Kim, C.H., Leitao, M.M., Chi, D.S., Sonoda, Y., Alektiar, K., DeLair, D.F., Barakat, R.R. and Abu-Rustum, N.R. (2012) The Importance of Applying a Sentinel Lymph Node Mapping Algorithm in Endometrial Cancer Staging: Beyond Removal of Blue Nodes. Gynecologic Oncology, 125, 531-535. https://doi.org/10.1016/j.ygyno.2012.02.021
|
[21]
|
Cormier, B., et al. (2011) Establishing a Sentinel Lymph Node Mapping Algorithm for the Treatment of Early Cervical Cancer. Gynecologic Oncology, 122, 275-280.
https://doi.org/10.1016/j.ygyno.2011.04.023
|
[22]
|
Tschernichovsky, R., Diver, E.J., Schorge, J.O. and Goodman, A. (2016) The Role of Lymphadenectomy versus Sentinel Lymph Node Biopsy in Early-Stage Endometrial Cancer: A Review of the Literature. American Journal of Clinical Oncology, 39, 516-521. https://doi.org/10.1097/COC.0000000000000302
|
[23]
|
Hagen, B., Valla, M., Aune, G., Ravlo, M., Abusland, A.B., Araya, E., Sundset, M. and Tingulstad, S. (2016) Indocyanine Green Fluorescence Imaging of Lymph Nodes during Robotic-Assisted Laparoscopic Operation for Endometrial Cancer. A Prospective Validation Study Using a Sentinel Lymph Node Surgical Algorithm. Gynecologic Oncology, 143, 479-483. https://doi.org/10.1016/j.ygyno.2016.10.029
|
[24]
|
Ehrisman, J., Secord, A.A., Berchuck, A., Lee, P.S., Di Santo, N., Lopez-Acevedo, M., Broadwater, G., Valea, F.A. and Havrilesky, L.J. (2016) Performance of Sentinel lymph Node Biopsy in High-Risk Endometrial Cancer. Gynecologic Oncology Reports, 17, 69-71. https://doi.org/10.1016/j.gore.2016.04.002
|
[25]
|
Khoury-Collado, F., et al. (2009) Improving Sentinel Lymph Node Detection Rates in Endometrial Cancer: How Many Cases Are Needed? Gynecologic Oncology, 115, 453-455. https://doi.org/10.1016/j.ygyno.2009.08.026
|
[26]
|
Eitan, R., et al. (2015) Robotic Blue-Dye Sentinel Lymph Node Detection for Endometrial Cancer—Factors Predicting Successful Mapping. European Journal of Surgical Oncology, 41, 1659-1663. https://doi.org/10.1016/j.ejso.2015.09.006
|
[27]
|
Papadia, A., Gasparri, M.L., Buda, A. and Mueller, M.D. (2017) Sentinel Lymph Node Mapping in Endometrial Cancer: Comparison of Fluorescence Dye with Traditional Radiocolloid and Blue. Journal of Cancer Research and Clinical Oncology, 143, 2039-2048. https://doi.org/10.1007/s00432-017-2501-8
|
[28]
|
Montgomery, L.L., Thorne, A.C., Van Zee, K.J., Fey, J., Heerdt, A.S., Gemignani, M., Port, E., Petrek, J., Cody, H.S. and Borgen, P.I. (2002) Isosulfan Blue Dye Reactions during Sentinel Lymph Node Mapping for Breast Cancer. Anesthesia & Analgesia, 95, 385-388. https://doi.org/10.1213/00000539-200208000-00026
|
[29]
|
Elisei, F., Crivellaro, C., Giuliani, D., Dolci, C., De Ponti, E., Montanelli, L., La Manna, M., Guerra, L., Arosio, M., Landoni, C., et al. (2017) Sentinel-Node Mapping in Endometrial Cancer Patients: Comparing SPECT/CT, Gamma-Probe and Dye. Annals of Nuclear Medicine, 31, 93-99.
https://doi.org/10.1007/s12149-016-1137-0
|
[30]
|
Kang, S., Yoo, H.J., Hwang, J.H., Lim, M.C., Seo, S.S. and Park, S.Y. (2011) Sentinel Lymph Node Biopsy in Endometrial Cancer: Meta-Analysis of 26 Studies. Gynecologic Oncology, 123, 522-527. https://doi.org/10.1016/j.ygyno.2011.08.034
|
[31]
|
Eriksson, A.G., Montovano, M., Beavis, A., Soslow, R.A., Zhou, Q., Abu-Rustum, N.R., Gardner, G.J., Zivanovic, O., Barakat, R.R., Brown, C.L., et al. (2016) Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Newly Diagnosed Uterine Cancer Undergoing Robotic Surgery. Annals of Surgical Oncology, 23, 2522-2528. https://doi.org/10.1245/s10434-016-5134-2
|
[32]
|
Papadia, A., et al. (2017) Sentinel Lymph Node Mapping in Patients with Stage I Endometrial Carcinoma: A Focus on Bilateral Mapping Identification by Comparing Radiotracer Tc99(m) with Blue Dye versus Indocyanine Green Fluorescent Dye. Journal of Cancer Research and Clinical Oncology, 143, 475-480.
https://doi.org/10.1007/s00432-016-2297-y
|
[33]
|
Sinno, A.K., Fader, A.N., Roche, K.L., Giuntoli, R.L. and Tanner, E.J. (2014) A Comparison of Colorimetric versus Fluorometric Sentinel Lymph Node Mapping during Robotic Surgery for Endometrial Cancer. Gynecologic Oncology, 134, 281-286. https://doi.org/10.1016/j.ygyno.2014.05.022
|
[34]
|
Tanner, E.J., Sinno, A.K., Stone, R.L., Levinson, K.L., Long, K.C. and Fader, A.N. (2015) Factors Associated with Successful Bilateral Sentinel Lymph Node Mapping in Endometrial Cancer. Gynecologic Oncology, 138, 542-547.
https://doi.org/10.1016/j.ygyno.2015.06.024
|
[35]
|
Leitao, M.M., Khoury-Collado, F., Gardner, G., Sonoda, Y., Brown, C.L., Alektiar, K.M., Hensley, M.L., Soslow, R.A., Barakat, R.R. and Abu-Rustum, N.R. (2013) Impact of Incorporating an Algorithm That Utilizes Sentinel Lymph Node Mapping during Minimally Invasive Procedures on the Detection of Stage IIIC Endometrial Cancer. Gynecologic Oncology, 129, 38-41.
https://doi.org/10.1016/j.ygyno.2013.01.002
|
[36]
|
Cormier, B., Rozenholc, A.T., Gotlieb, W., Plante, M., Giede, C. and Communities of Practice Group of Society of Gynecologic Oncology of C (2015) Sentinel Lymph Node Procedure in Endometrial Cancer: A Systematic Review and Proposal for Standardization of Future Research. Gynecologic Oncology, 138, 478-485.
https://doi.org/10.1016/j.ygyno.2015.05.039
|
[37]
|
Bogani, G., Martinelli, F., Ditto, A., Signorelli, M., Chiappa, V., Recalcati, D., Lorusso, D. and Raspagliesi, F. (2016) Sentinel Lymph Node Detection in Endometrial Cancer: Does Injection Site Make a Difference? Journal of Gynecologic Oncology, 27, e23. https://doi.org/10.3802/jgo.2016.27.e23
|
[38]
|
Rossi, E.C., Kowalski, L.D., Scalici, J., Cantrell, L., Schuler, K., Hanna, R.K., Method, M., Ade, M., Ivanova, A. and Boggess, J.F. (2017) A Comparison of Sentinel Lymph Node Biopsy to Lymphadenectomy for Endometrial Cancer Staging (FIRES Trial): A Multicentre, Prospective, Cohort Study. The Lancet Oncology, 18, 384-392.
https://doi.org/10.1016/S1470-2045(17)30068-2
|
[39]
|
Soliman, P.T., et al. (2017) A Prospective Validation Study of Sentinel Lymph Node Mapping for High-Risk Endometrial Cancer. Gynecologic Oncology, 146, 234-239.
https://doi.org/10.1016/j.ygyno.2017.05.016
|
[40]
|
Bodurtha Smith, A.J., Fader, A.N. and Tanner, E.J. (2017) Sentinel Lymph Node Assessment in Endometrial Cancer: A Systematic Review and Meta-Analysis. American Journal of Obstetrics & Gynecology, 216, 459-476e10.
https://doi.org/10.1016/j.ajog.2016.11.1033
|
[41]
|
Leitao, M.M. (2016) Sentinel Lymph Node Mapping in Patients with Endometrial Carcinoma: Less Can Be More. Current Obstetrics and Gynecology Reports, 5, 279-285. https://doi.org/10.1007/s13669-016-0178-7
|
[42]
|
Bogani, G., Ditto, A., Leone Roberti Maggiore, U., Lorusso, D. and Raspagliesi, F. (2017) Sentinel-Lymph-Node Mapping in Endometrial Cancer. The Lancet Oncology, 18, e234. https://doi.org/10.1016/S1470-2045(17)30247-4
|
[43]
|
Geppert, B., Lonnerfors, C., Bollino, M. and Persson, J. (2018) Sentinel Lymph Node Biopsy in Endometrial Cancer-Feasibility, Safety and Lymphatic Complications. Gynecologic Oncology, 148, 491-498.
https://doi.org/10.1016/j.ygyno.2017.12.017
|
[44]
|
Zahl Eriksson, A.G., Ducie, J., Ali, N., McGree, M.E., Weaver, A.L., Bogani, G., Cliby, W.A., Dowdy, S.C., Bakkum-Gamez, J.N., Abu-Rustum, N.R., et al. (2016) Comparison of a Sentinel Lymph Node and a Selective Lymphadenectomy Algorithm in Patients with Endometrioid Endometrial Carcinoma and Limited Myometrial Invasion. Gynecologic Oncology, 140, 394-399.
https://doi.org/10.1016/j.ygyno.2015.12.028
|
[45]
|
Ducie, J.A., Eriksson, A.G.Z., Ali, N., McGree, M.E., Weaver, A.L., Bogani, G., Cliby, W.A., Dowdy, S.C., Bakkum-Gamez, J.N., Soslow, R.A., et al. (2017) Comparison of a Sentinel Lymph Node Mapping Algorithm and Comprehensive Lymphadenectomy in the Detection of Stage IIIC Endometrial Carcinoma at Higher Risk for Nodal Disease. Gynecologic Oncology, 147, 541-548.
https://doi.org/10.1016/j.ygyno.2017.09.030
|
[46]
|
Buda, A., Di Martino, G., Restaino, S., De Ponti, E., Monterossi, G., Giuliani, D., Ercoli, A., Dell’Orto, F., Dinoi, G., Grassi, T., et al. (2017) The Impact on Survival of Two Different Staging Strategies in Apparent Early Stage Endometrial Cancer Comparing Sentinel Lymph Nodes Mapping Algorithm and Selective Lymphadenectomy: An Italian Retrospective Analysis of Two Reference Centers. Gynecologic Oncology, 147, 528-534. https://doi.org/10.1016/j.ygyno.2017.09.033
|
[47]
|
Kataoka, F., Susumu, N., Yamagami, W., Kuwahata, M., Takigawa, A., Nomura, H., Takeuchi, H., Nakahara, T., Kameyama, K. and Aoki, D. (2016) The Importance of Para-Aortic Lymph Nodes in Sentinel Lymph Node Mapping for Endometrial Cancer by Using Hysteroscopic Radio-Isotope Tracer Injection Combined with Subserosal Dye Injection: Prospective Study. Gynecologic Oncology, 140, 400-404.
https://doi.org/10.1016/j.ygyno.2015.12.023
|
[48]
|
Ruscito, I., Gasparri, M.L., Braicu, E.I., Bellati, F., Raio, L., Sehouli, J., Mueller, M.D., Panici, P.B. and Papadia, A. (2016) Sentinel Node Mapping in Cervical and Endometrial Cancer: Indocyanine Green versus Other Conventional Dyes—A Meta-Analysis. Annals of Surgical Oncology, 23, 3749-3756.
https://doi.org/10.1245/s10434-016-5236-x
|
[49]
|
Holloway, R.W., Abu-Rustum, N.R., Backes, F.J., Boggess, J.F., Gotlieb, W.H., Jeffrey Lowery, W., Rossi, E.C., Tanner, E.J. and Wolsky, R.J. (2017) Sentinel Lymph Node Mapping and Staging in Endometrial Cancer: A Society of Gynecologic Oncology Literature Review with Consensus Recommendations. Gynecologic Oncology, 146, 405-415. https://doi.org/10.1016/j.ygyno.2017.05.027
|
[50]
|
Plante, M., Stanleigh, J., Renaud, M.C., Sebastianelli, A., Grondin, K. and Gregoire, J. (2017) Isolated Tumor Cells Identified by Sentinel Lymph Node Mapping in Endometrial Cancer: Does Adjuvant Treatment Matter? Gynecologic Oncology, 146, 240-246. https://doi.org/10.1016/j.ygyno.2017.05.024
|
[51]
|
St Clair, C.M., Eriksson, A.G., Ducie, J.A., Jewell, E.L., Alektiar, K.M., Hensley, M.L., Soslow, R.A., Abu-Rustum, N.R. and Leitao, M.M. (2016) Low-Volume Lymph Node Metastasis Discovered during Sentinel Lymph Node Mapping for Endometrial Carcinoma. Annals of Surgical Oncology, 23, 1653-1659.
https://doi.org/10.1245/s10434-015-5040-z
|
[52]
|
Ballester, M., Naoura, I., Chereau, E., Seror, J., Bats, A.S., Bricou, A. and Darai, E. (2013) Sentinel Node Biopsy Upstages Patients with Presumed Low- and Intermediate-Risk Endometrial Cancer: Results of a Multicenter Study. Annals of Surgical Oncology, 20, 407-412. https://doi.org/10.1245/s10434-012-2683-x
|